FOLLOWING gargantuan global efforts against COVID-19, tuberculosis is once again the world's biggest infectious killer, a top expert has told AFP, lamenting the lack of focus on rooting out TB.
Mel Spigelman, president of the non-profit TB Alliance, hailed the swift and dramatic progress to rein in the COVID pandemic, with a vast array of safe and effective vaccines, tests and treatments developed in the space of two years.
"But the juxtaposition with TB is pretty stark," he said in a recent interview.
Tuberculosis, once called consumption, was the world's biggest infectious killer before the arrival of COVID-19, with 1.5 million people dying from the disease each year.
With global COVID deaths steadily declining, "TB has regained the dubious distinction," Spigelman said.
The TB Alliance, a non-profit working to develop and deliver faster-acting and affordable drugs against the disease, especially in poorer countries, points out that based on the annual death rate, TB kills 4,109 people a day.
That compares to 1,449 people a day dying due to COVID, calculated from the 40,578 deaths reported in the past 28 days on the Johns Hopkins University dashboard.
- 'Major setback' -
But unlike COVID, there appears to be little, and even waning, interest in taking on TB.
In fact, the pandemic had a devastating impact on efforts to battle tuberculosis, with TB hospitals taken over for COVID care, and lockdowns preventing patients from coming in for diagnosis and care.
As a result, the number of annual TB deaths swelled for the first time in a decade in 2020.
"We went from what I honestly consider to be unbelievably slow progress, but at least progress, to a reversal," Spigelman said.
"It has been a major setback,” he said.
While billions of dollars were being thrown at the COVID fight, global economic woes and swelling geopolitical tensions prompted top donors towards the TB battle to tighten their purse-strings.
Most of the TB Alliance donors suddenly could not commit more than a year of funding at a time and slashed the amounts given, with traditional top donor Britain providing no funding at all this year.
"I am very worried that the progress that has been made, which has already been eroded by COVID... could be even further eroded," Spigelman said.
- 'Game-changer' -
Ironically, these difficulties are coming amid a revolution in the treatment of drug-resistant TB.
Around five percent of the 9.5 million people who contract TB each year are resistant to commonly-prescribed antibiotics, making them difficult to treat.
Until recently, "the situation with drug resistant TB was horrible," Spigelman said.
Patients were forced to take five to eight pills a day, and often a daily injection, for up to two years, with horrible side effects and a cure-rate of just 20 to 30 percent.
But a new drug regimen BPaL, first approved by the US Food and Drug Administration in 2019, consists of just three pills a day for six months, and has far fewer side-effects and a cure-rate of 90 percent, Spigelman said.
"I think it'll really be an amazing game-changer."
- 'Could be eradicated' -
He acknowledged though that "we are closer to the beginning of this journey than we are to the end of it," pointing out that resources are needed to roll out the new regimen to the patients who need it.
And with TB, resources are always in short supply.
Spigelman blamed the lacking urgency around rooting out TB on it being "a disease of the poor".
"If rich people around the world were getting it, I think we would see a very different response," he said.
As things stand, candidate vaccines against TB have been languishing, with no funding available to develop them, and there have been no attempts to roll out easy testing like the kind developed for COVID.
Spigelman said that with the kind of resources poured into COVID, TB could be wiped out altogether.
"If the resources were there, I bet you it could be eradicated."
ETX Studio
Wed Oct 26 2022
Around five per cent of the 9.5 million people who contract TB each year are resistant to commonly-prescribed antibiotics, making them difficult to treat. - ETX Studio
PRK KKB: Ahmad Zahid yakin ahli UMNO sokong calon Kerajaan Perpaduan
Ahmad Zahid yakin ahli parti itu di DUN Kuala Kubu Baharu akan memberikan sokongan kepada calon Kerajaan Perpaduan pada PRK DUN itu, 11 Mei ini.
Piala Thomas: Malaysia diundi bertemu Jepun di suku akhir
Skuad kebangsaan akan meneruskan kempen demi misi membawa Piala Thomas pulang ke tanah air sejak kali terakhir memenanginya pada 1992.
Kenaikan gaji: Fahami konteks, berlaku adil buat perbandingan - Fahmi
Isu timbul selepas ada pihak mendakwa kenaikan paling tinggi adalah sebanyak 35 peratus pada era pentadbiran perdana menteri kelima, Tun Abdullah Ahmad Badawi.
Kerajaan sedia terima kritikan, namun, tidak bertolak ansur sentimen 3R - PM Anwar
Kebebasan bersuara yang diperuntukkan dalam Perlembagaan Persekutuan bukan bermakna kebebasan untuk mencerca dan memaki hamun sesuka hati.
ADUN Sungai Bakap ditidurkan akibat keradangan perut
Muhammad Fauzi dimaklumkan oleh ahli keluarga Nor Zamri berhubung keadaan kesihatan beliau yang ketika ini ditidurkan.
NCEC setuju transformasi perundangan sisa pepejal diadakan - KPKT
Mesyuarat NCEC bersetuju mengadakan transformasi perundangan bagi sisa pepejal.
AirAsia yakin mampu harungi pergerakan mata wang tidak menggalakkan, kenaikan harga bahan api
AirAsia yakin mampu tangani kenaikan harga bahan api dan pergerakan mata wang tidak menggalakkan yang berpanjangan, yang terus meningkatkan cabaran global.
JPN pergiat masuk pedalaman kampung Orang Asli, daftar sijil kelahiran, MyKad
JPN mempergiatkan inisiatif memasuki kawasan pedalaman Orang Asli bagi mengurangkan kelewatan daftar kelahiran dan MyKad komuniti itu.
Semakan gaji penjawat awam adalah wajar untuk hadapi inflasi - Ahli ekonomi
Semakan gaji penjawat awam adalah munasabah, sudah lama tertunggak dan wajar untuk menghadapi inflasi, kata seorang ahli ekonomi.
Isu terpalit FAM tak jejas Harimau Malaya - Faisal
Faisal sifatkan barisan pemain skuad kebangsaan tidak terjejas dengan isu yang terpalit Persatuan Bolasepak Malaysia (FAM) baru-baru ini.
Tibi terpendam cabaran terbesar menuju negara bebas tibi
Antara punca peningkatan kes tibi atau batuk kering ini adalah kerana pandemik COVID-19 yang mengganggu akses kepada diagnosis dan rawatan tibi.
Dunia diseru bentuk sinergi atasi penyakit tibi
Terdapat lebih sejuta sukarelawan di China yang berbakti untuk menyebarluaskan ilmu tentang TB selain menghulurkan bantuan kepada para pesakit.
Kes tibi di Malaysia masih tinggi - Pakar
Jumlah kes pesakit tibi atau batuk kering masih tinggi di negara ini walaupun pelbagai rawatan diperkenalkan dan peningkatan pengesanan kes telah dijalankan, kata pakar perubatan respiratori.
Pematuhan SOP penginapan pekerja perlu diambil serius
Timbalan Menteri Sumber Manusia Awang Hashim berkata penginapan pekerja juga mempunyai hubung kait dengan isu penularan COVID-19.
Semut hurung mata pesakit meninggal dunia
Gambar yang memaparkan semut mengerumuni mata mayat pesakit yang dibiarkan di hospital berkenaan selama beberapa jam turut menjadi tular di media sosial sejak kelmarin.
TPM terima kunjungan hormat Komunikator Sains Terbaik Dunia
Dr Wan Azizah dalam satu kenyataan bersempena pertemuan itu berkata kejayaan Siti Khayriyyah itu menunjukkan rakyat Malaysia terutamanya wanita mampu bersaing di persada antarabangsa.